Lanx Inc.

EnteroMedics CEO Obesity device firm EnteroMedics Inc. appointed Dan Gladney president and CEO, effective Nov. 16. Gladney will replace current president, CEO and chairman Mark Knudson , who wi

Each year, START-UP reviews the sectors of the medical device industry that received private funding to identify investment trends and to discover what will be fueling the growth of medtech strategi

Traditionally, the market for medical device initial public offerings of stock trails the opening of the biopharma window by a year or two. But the string of biopharma IPOs over the past two years has

IN VITRO DIAGNOSTICS Mergers & Acquisitions Clinical Genomics Technologies Pty. Ltd. Quest Diagnostics Inc. Enterix Inc. As part of a continued effort to focus on its Diagnostics Information Services